Methotrexate: who would have predicted its importance in rheumatoid arthritis?

Overview of attention for article published in Arthritis Research & Therapy, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 4 news stories from 3 outlets.

Dr Sidney Farber If you could go back in time 75 years and tell Dr Sidney Farber, the developer of methotrexate for cancer…

If you could go back in time 75 years and tell Dr. Sidney Farber, the developer of methotrexate for cancer therapy, that 21st-cen…

Dr Sidney Farber If you could go back in time 75 years and tell Dr Sidney Farber, the developer of methotrexate for cancer…

Related Biotechnology, Pharmaceutical and Healthcare News Original Article: Methotrexate: who would have predicted its…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.